Sébastien Apcher

1.5k total citations
32 papers, 946 citations indexed

About

Sébastien Apcher is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Sébastien Apcher has authored 32 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Immunology and 11 papers in Oncology. Recurrent topics in Sébastien Apcher's work include Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (9 papers) and Ubiquitin and proteasome pathways (8 papers). Sébastien Apcher is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (9 papers) and Ubiquitin and proteasome pathways (8 papers). Sébastien Apcher collaborates with scholars based in France, Sweden and Czechia. Sébastien Apcher's co-authors include Robin Fåhræus, Chrysoula Daskalogianni, Bénédicte Manoury, Marco M. Candeias, Fabrice Lejeune, G. Millot, Alexander Scherl, Simon Dawson, Hiroaki Higashitsuji and Bořivoj Vojtěšek and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Sébastien Apcher

31 papers receiving 937 citations

Peers

Sébastien Apcher
Jack Liao Canada
Suvana S. Lam United States
Joseph Bekisz United States
Romi Gupta United States
Andreas Begitt United Kingdom
Tuhina Mazumdar United States
Stephen Ma Australia
Troy E. Messick United States
Sébastien Apcher
Citations per year, relative to Sébastien Apcher Sébastien Apcher (= 1×) peers Alessandro Natoni

Countries citing papers authored by Sébastien Apcher

Since Specialization
Citations

This map shows the geographic impact of Sébastien Apcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sébastien Apcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sébastien Apcher more than expected).

Fields of papers citing papers by Sébastien Apcher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sébastien Apcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sébastien Apcher. The network helps show where Sébastien Apcher may publish in the future.

Co-authorship network of co-authors of Sébastien Apcher

This figure shows the co-authorship network connecting the top 25 collaborators of Sébastien Apcher. A scholar is included among the top collaborators of Sébastien Apcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sébastien Apcher. Sébastien Apcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pla, Marika, Chrysoula Daskalogianni, Rodrigo Prado Martins, et al.. (2023). Major histocompatibility class I antigenic peptides derived from translation of pre-mRNAs generate immune tolerance. Proceedings of the National Academy of Sciences. 120(7). e2208509120–e2208509120. 4 indexed citations
2.
Aldea, Mihaela, Luc Friboulet, Sébastien Apcher, et al.. (2023). Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision?. ESMO Open. 8(5). 101642–101642. 21 indexed citations
3.
Apcher, Sébastien, Bořivoj Vojtěšek, & Robin Fåhræus. (2023). In search of the cell biology for self- versus non-self- recognition. Current Opinion in Immunology. 83. 102334–102334.
4.
Cerrato, Giulia, Dolor Renko, Alain Pruvost, et al.. (2022). Biological Investigation of a Water-Soluble Isoginkgetin-Phosphate Analogue, Targeting the Spliceosome with In Vivo Antitumor Activity. Journal of Medicinal Chemistry. 65(6). 4633–4648. 4 indexed citations
5.
Cerruti, Fulvia, Angela Cattaneo, Angela Bachi, et al.. (2021). PA28γ–20S proteasome is a proteolytic complex committed to degrade unfolded proteins. Cellular and Molecular Life Sciences. 79(1). 45–45. 12 indexed citations
6.
Renko, Dolor, David Bouyssié, Emmanuelle Mouton‐Barbosa, et al.. (2021). Isoginkgetin derivative IP2 enhances the adaptive immune response against tumor antigens. Communications Biology. 4(1). 269–269. 14 indexed citations
7.
Apcher, Sébastien, et al.. (2021). mRNA translation from an antigen presentation perspective: A tribute to the works of Nilabh Shastri. Molecular Immunology. 141. 305–308. 3 indexed citations
8.
Bignon, Jérôme, Guillaume Bernadat, Mohamed Benchekroun, et al.. (2017). A fluorine scan of a tubulin polymerization inhibitor isocombretastatin A-4: Design, synthesis, molecular modelling, and biological evaluation. European Journal of Medicinal Chemistry. 143. 473–490. 30 indexed citations
9.
Duvallet, Emilie, Takahiro Yamazaki, Chrysoula Daskalogianni, et al.. (2016). Exosome-driven transfer of tumor-associated Pioneer Translation Products (TA-PTPs) for the MHC class I cross-presentation pathway. OncoImmunology. 5(9). e1198865–e1198865. 23 indexed citations
10.
Apcher, Sébastien, Rodrigo Prado Martins, & Robin Fåhræus. (2016). The source of MHC class I presented peptides and its implications. Current Opinion in Immunology. 40. 117–122. 16 indexed citations
11.
Apcher, Sébastien, Chrysoula Daskalogianni, & Robin Fåhræus. (2015). Pioneer translation products as an alternative source for MHC-I antigenic peptides. Molecular Immunology. 68(2). 68–71. 10 indexed citations
12.
Apcher, Sébastien, Bénédicte Manoury, & Robin Fåhræus. (2012). The role of mRNA translation in direct MHC class I antigen presentation. Current Opinion in Immunology. 24(1). 71–76. 20 indexed citations
13.
Karlin, Lionel, Stéphanie Harel, Enguerran Mouly, et al.. (2012). The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo. Haematologica. 97(7). 1101–1109. 39 indexed citations
14.
Eisenlohr, Laurence C., et al.. (2011). Beyond the classical: Influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways. Immunologic Research. 51(2-3). 237–248. 11 indexed citations
15.
Apcher, Sébastien, Chrysoula Daskalogianni, Bénédicte Manoury, & Robin Fåhræus. (2010). Epstein Barr Virus-Encoded EBNA1 Interference with MHC Class I Antigen Presentation Reveals a Close Correlation between mRNA Translation Initiation and Antigen Presentation. PLoS Pathogens. 6(10). e1001151–e1001151. 68 indexed citations
16.
Daskalogianni, Chrysoula, Sébastien Apcher, Marco M. Candeias, et al.. (2008). Gly-Ala Repeats Induce Position- and Substrate-specific Regulation of 26 S Proteasome-dependent Partial Processing. Journal of Biological Chemistry. 283(44). 30090–30100. 45 indexed citations
17.
Candeias, Marco M., Darren Powell, Eva Roubalová, et al.. (2006). Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiation. Oncogene. 25(52). 6936–6947. 93 indexed citations
18.
Apcher, Sébastien, Robin Fåhræus, & Bénédicte Manoury. (2004). Epstein–Barr virus: exploiting the immune system by interfering with defective ribosomal products. Microbes and Infection. 6(13). 1212–1218. 8 indexed citations
19.
Dawson, Simon, Sébastien Apcher, Maureen Mee, et al.. (2002). Gankyrin Is an Ankyrin-repeat Oncoprotein That Interacts with CDK4 Kinase and the S6 ATPase of the 26 S Proteasome. Journal of Biological Chemistry. 277(13). 10893–10902. 109 indexed citations
20.
Jarrousse, Anne‐Sophie, et al.. (1999). Relationships between proteasomes and viral gene products. Molecular Biology Reports. 26(1-2). 113–117. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026